ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Prezista 100 mg/ml, orale Suspension - Flasche(n)
65381001 Janssen-Cilag AG
Prezista 100 mg/ml, orale Suspension23.07.2015
  23.07.2015
Darunavir (J05AE10) 
WHO-DDD 
Flasche(n)
08.03. 
A  
No 
IPCI
PR  
k.A.PR
  
7680653810015Synthetika
  
Composition
darunavirum 100 mg ut darunavirum ethanolum, hydroxypropylcellulosum, cellulosum microcristallinum, carmellosum natricum, acidum citricum monohydricum, sucralosum, acidum hydrochloridum concentratum, aromatica (Geschmacksüberdeckungsaroma), aromatica (Erdbeer), E 219 3.43 mg, aqua purificata ad suspensionem pro 1 ml corresp. natrium 570 µg.
Packungsbestandteile
Suspension (oral)
 
 
Active AgentDose
Darunavir100 mg/ml
 
Inactive agentsDoseadditional_information
Citric Acid Monohydrate  
Acidum Hydrochloridum Concentratum  
Aromatica (Erdbeer)  
Aromatica (Geschmacksüberdeckungsaroma)  
Carmellose Sodium  
Cellulosum Microcristallinum  
E 2193.43 mg/mlconserv.
Hydroxypropylcellulosum  
Sucralosum  
Source
Data was imported : 06.11.2020 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home